histological subtypes

Related by string. histological subtype * Histological : cytological histological analysis . histological diagnosis . Histological analysis . histological examination . Histological examination . histological / Subtype . Subtypes : H7 subtype . H7 subtypes . distinct subtypes . Zaire subtype . H5 subtype . subtype selective NMDA receptor . squamous subtype . predominant subtype * *

Related by context. Frequent words. (Click for all words.) 64 carcinoid 64 breast carcinoma 64 HER2 positive metastatic breast 63 xenograft models 63 malignant lesions 63 KRAS mutations 62 meningiomas 62 papillary 62 hematologic malignancies 62 prognostic significance 62 carcinoid tumors 62 histologically 61 metastatic bone 61 squamous 61 distant metastasis 61 neoplasm 61 lymph node metastasis 61 subtypes 61 therapeutic regimens 61 immunohistochemical 61 neoplastic 61 lymph node metastases 61 molecular biomarkers 61 malignant pleural mesothelioma 60 ischemic cardiomyopathy 60 metastatic lesions 60 morphologic 60 histologic 60 multivariate analyzes 60 biochemical recurrence 60 resectable 60 colorectal carcinoma 60 prognostic factors 60 malignancies 60 gastric cancers 60 thyroid nodules 59 liver metastases 59 Azedra 59 etiologies 59 soft tissue sarcomas 59 histopathologic 59 non squamous 59 hematologic cancers 59 KRAS wild 59 EGFR mutations 59 myeloproliferative disorders 58 lymphadenectomy 58 Response Evaluation Criteria 58 neoplasms 58 heavily pretreated 58 ependymoma 58 atherothrombosis 58 genetic determinants 58 prognostic factor 58 glioblastoma multiforme GBM 58 HCV genotypes 58 epithelial ovarian cancer 58 ovarian breast 58 histopathological 58 lymph node dissection 58 genetic polymorphisms 58 Recurrence Score 58 metastatic liver 58 cerebrospinal fluid CSF 58 lymph node involvement 58 metabolic parameters 58 ocular melanoma 58 neoadjuvant therapy 58 epithelia 58 prognostic marker 58 FDG PET 58 Lymphomas 58 androgen deprivation 58 atherosclerotic disease 58 chemotherapy regimens 57 methylation patterns 57 ductal 57 microRNA expression 57 multiple myeloma MM 57 cholangiocarcinoma 57 superficial bladder cancer 57 estrogen receptor ER 57 chronicity 57 heavily pretreated patients 57 pathologic 57 breast lesions 57 epithelial cancers 57 nodular 57 gene expression profiles 57 adenocarcinomas 57 enzastaurin 57 paclitaxel eluting stents 57 grade gliomas 57 liver transplant recipients 57 EGFR inhibitors 57 endometrial cancers 56 systemic lupus erythematosus SLE 56 pheochromocytoma 56 carcinomas 56 grade glioma 56 haematological

Back to home page